# AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

> **NCT00107250** · PHASE1 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 50 (actual)

## Conditions studied

- Colorectal Cancer
- Lung Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** capecitabine
- **DRUG:** carboplatin
- **DRUG:** cediranib maleate
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00107250
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01-21
- **Primary completion:** 2009-10-23
- **Final completion:** 2011-01-18
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00107250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00107250, "AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00107250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*